GlassScriptPhysician profile
Evelyn Bryon
NPI 1548767577
$1,034.22
in general payments reported to CMS, 2019-2025
14 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.39 · 2023: $177 · 2024: $437 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $240.19 | 2023-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $229.57 | 2024-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $116.30 | 2023-2024 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $107.34 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $71.16 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $63.69 | 2025 | |
| Merck Sharp & Dohme LLC | $43.72 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Abbvie INC. | $34.04 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.22 | 2024 | Jardiance |
| Hologic Sales and Service, LLC | $26.67 | 2025 | Thinprep 2000 Processor, Aptima |
| Glaxosmithkline, LLC. | $20.98 | 2023 | Shingrix |
| Axsome Therapeutics, INC. | $20.01 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $16.86 | 2023 | Livalo |
| Currax Pharmaceuticals LLC | $14.47 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Bryon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.